510(k) K014233
K014233 is an FDA 510(k) premarket notification submitted by Trinity Biotech, Plc for the device "CAPTIAM SYPHILIS-G ASSAY". The FDA issued a decision of Substantially Equivalent on January 24, 2002. The device falls under product code LIP (Enzyme Linked Immunoabsorption Assay, Treponema Pallidum), a Class II device regulated under 21 CFR 866.3830. Trinity Biotech, Plc has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- January 24, 2002
- Date Received
- December 26, 2001
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Enzyme Linked Immunoabsorption Assay, Treponema Pallidum
- Device Class
- Class II
- Regulation Number
- 866.3830
- Review Panel
- MI
- Submission Type